HLA class II allele and haplotype frequencies in Iranian patients with acute myelogenous leukemia and control group

Iranian Journal of Allergy, Asthma and Immunology

Volumn 5, Issue 3, 2006, Pages 115-119

  Sarafnejad, Abdolfattah ^a   Khosravi, Farideh ^b   Alimoghadam, Kamran ^c   Dianat, Saied ^b   Ansaripour, Bita ^b   Moradi, Batoul ^b   Dorkhosh, Shahin ^b   Amirzargar, Aliakbar ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute Myelogenous Leukemia; HLA class II; Polymorphism

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA FINGERPRINTING; GENE FREQUENCY; HAPLOTYPE; HEREDITY; HLA TYPING; HUMAN; INFORMED CONSENT; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IRAN; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, ACUTE;

EID: 33750075453     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. O'Brien K, Cokkinides V, Jemal A, Cardinez CJ, Murray T, Samuels A, et al. Cancer statistics for Hispanics, 2003. CA Cancer J Clin 2003; 53(4):208-26.
2. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 2003; 138(10):819-30.
3. McKenzie SB. Advances in understanding the biology and genetics of acute myelocytic leukemia. Clin Lab Sci 2005; 18(1):28-37.
4. Gilliland DG, Jordan CT, Felix CA. The Molecular Basis of Leukemia. Hematology 2004; 1:80-97.
5. Sandler DP. Epidemiology of acute myelogenous leukemia. Semin Oncol 1987; 14(4):359-64.
6. Byrd JC, Lawrence D, Arthur DC, Pettenati MJ, Tantravahi R, Qumsiyeh M, et al. Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461. Clin Cancer Res 1998; 4(5):1235-41
7. Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 7(12):1975-86.
8. Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul, C. Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction. Br J Haematol 2000; 108:724-8.
9. Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997; 66(3):345-51.
10. Symeonidis A, Kourakli A, Katevas P, Perraki M, Tiniakou M, Matsouka P, et al. Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis. Eur J Haematol 1991; 47(4):277-81.
11. Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, et al. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 1996; 20(11-12):891-900.
12. Dausset J. The major histocompatibility complex in man. Science 1981; 213(4515):1469-74.
13. Seremetis S, Cuttner J, Winchester R. Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J Clin Invest 1985; 76(4):1391-7.
14. Gowans D, O'Sullivan A, Rollinson S, Roddam P, Groves M, Fegan C, et al. Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia in search of an autoimmune aetiology. Br J Haematol 2002; 117(3):541-5.
15. Li D, Xi B, Liu HY, Yu Y. Association of gene HLA-class I with leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005; 13(4):563-6.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3):1215
17. Emtestam L, Zetterquist H, Olerup O. HLA-DR, -DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms. J Invest Dermatol 1993; 100(3):271-4
18. Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G, et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 2001; 62(11):1234-8.
19. Haldane Jbs. The estimation and significance of the logarithm of a ratio of frequency. Ann Hum Genet 1956; 20: 309.
20. Vasmel WL, Zijlstra M, Radaszkiewicz T, Leupers CJ, de Goede RE, Melief CJ. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas. J virol 1988; 62(9):3156-66.